Effect of a topical gel containing Sumac extract and Cloxacillin on diabetic foot ulcer
Phase 2
Recruiting
- Conditions
- Condition 1: Diabetic foot ulcer caused by type 1 diabetes. Condition 2: Diabetic foot ulcer caused by type 2 diabetes.Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangreneType 2 diabetes mellitus with diabetic peripheral angiopathy without gangreneE10.51E11.51
- Registration Number
- IRCT20220310054247N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patients with type 1 or 2 Diabetes
Age 30 years or older
Grade 1 and 2 diabetic ulcers according to Wagner classification system
Adherence to routine diabetes treatments
Ankle Brachial Index (ABI) greater than 0.7
Exclusion Criteria
Pregnancy or Breastfeeding
Presence of infection in the wound before admission
Presence of neoplasia
Use of immunosuppressive drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wound area and dimensions. Timepoint: Weekly for 8 weeks. Method of measurement: Photography of ulcers and Computer software.;Presence or absence of infection in the wound. Timepoint: Weekly for 8 weeks. Method of measurement: Wound examination and Visual observation.
- Secondary Outcome Measures
Name Time Method Incidence of side effects. Timepoint: Evaluation will be weekly from the first week to the eighth week. Method of measurement: Asking the patient and Examining the wound by the visitor (symptoms such as burning, itching, redness, etc. while using the gel).;Tolerability. Timepoint: Evaluation will be weekly from the first week to the eighth week. Method of measurement: Ask the patient if there is any discomfort while taking the drug or If there is any factor that makes the patient reluctant to continue treatment and the cause is related to the gel used.;Pain assessment. Timepoint: Before the intervention and the end of the eighth week. Method of measurement: The patient scores from one to ten, depending on the amount of pain he feels.(Visual Analogue Scale).;Quality of life score. Timepoint: Before the intervention and the end of the eighth week. Method of measurement: Questionnaire for quality of life of patients with diabetic foot ulcers.(Designed by Johnson in the UK, 1995).